Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr Hansen AsfiledCriticalChr Hansen As
Publication of AR094622A1publicationCriticalpatent/AR094622A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente se refiere al campo de la bioprotección, en particular a La cepa CHCC14676 del Lactobacillus paracasei, con número de acceso DSM25612. Además, la presente se refiere a una composición antifúngica que comprende la cepa; a una composición antifúngica que comprende la cepa y al menos una cepa del Lactobacillus rhamnosus; a un alimento, pienso y productos farmacéuticos que comprenden dicha composición antifúngica; un método para fabricar dicho alimento, pienso y productos farmacéuticos; a un método para reducir el contenido de levaduras y mohos de tal alimento, pienso y productos farmacéuticos y a los usos de La composición antifúngica.This refers to the field of bioprotection, in particular Lactobacillus paracasei strain CHCC14676, with accession number DSM25612. In addition, this refers to an antifungal composition comprising the strain; to an antifungal composition comprising the strain and at least one strain of Lactobacillus rhamnosus; to a food, feed and pharmaceutical products comprising said antifungal composition; a method for manufacturing said food, feed and pharmaceuticals; to a method to reduce the yeast and mold content of such food, feed and pharmaceuticals and to the uses of the antifungal composition.
ARP130101142A2012-04-092013-04-09
BIOPROTECTION USING CEPAS LACTOBACILLUS PARACASEI
AR094622A1
(en)
Composition for use in brain growth and / or cognitive development and / or psychomotor development comprising at least one long chain polyunsaturated fatty acid (lc-pufa), at least one probiotic and a mixture of oligosaccharides; Use of the composition.
Symbiotic composition comprising a bifidobacterium probiotic strain and an oligosaccharide component comprising arabino xyl oligosaccharides, useful for inhibiting infection by pathogens in the colon; and food composition that comprises it.